Mathers Edward T. - 16 Jun 2023 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
4
Filing time
21 Jun 2023, 19:24:52 UTC
Previous filing
15 Jun 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +62,500 $0.000000 62,500 16 Jun 2023 Common Stock 62,500 $0.9900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.